Changes in plasma protein binding have little clinical relevance

被引：575

作者：

Benet, LZ ^{[1
]}

Hoener, BA ^{[1
]}

机构：

[1] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 03期

关键词：

D O I：

10.1067/mcp.2002.121829

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：115 / 121

页数：7

共 20 条

[11]

Rowland M., 2011, Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications, V4th ed.

[12] WHAT IS THE TRUE CLINICAL-SIGNIFICANCE OF PLASMA-PROTEIN BINDING DISPLACEMENT INTERACTIONS [J].

SANSOM, LN ;

EVANS, AM .

DRUG SAFETY, 1995, 12 (04) :227-233

[13] PLASMA-PROTEIN DISPLACEMENT INTERACTIONS ARE RARELY OF CLINICAL SIGNIFICANCE [J].

SELLERS, EM .

PHARMACOLOGY, 1979, 18 (05) :225-227

[14] INTERACTION BETWEEN DIFLUNISAL AND WARFARIN [J].

SERLIN, MJ ;

MOSSMAN, S ;

SIBEON, RG ;

TEMPERO, KF ;

BRECKENRIDGE, AM .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) :493-498

[15]

SHEINER LB, 1979, CLIN PHARMACOL THER, V25, P358

[16]

THUMMEL KE, 2001, GOODMAN GILMANS PHAR, P1924

[17] PLASMA AND TISSUE BINDING CONSIDERATIONS IN DRUG DISPOSITION [J].

WILKINSON, GR .

DRUG METABOLISM REVIEWS, 1983, 14 (03) :427-465

[18]

WILKINSON GR, 1975, CLIN PHARMACOL THER, V18, P377

[19]

WINTER ME, 1994, APPL THER, P313

[20] DIFFERENTIATION OF ABSORPTION AND FIRST-PASS GUT AND HEPATIC-METABOLISM IN HUMANS - STUDIES WITH CYCLOSPORINE [J].

WU, CY ;

BENET, LZ ;

HEBERT, MF ;

GUPTA, SK ;

ROWLAND, M ;

GOMEZ, DY ;

WACHER, VJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (05) :492-497

← 1 2 →